Mark Fishman reflects on 10 years of NIBR

Mark Fishman started heading up research & development (R&D) at Novartis, as President of the Novartis Institutes for BioMedical Research (NIBR), 10 years ago. Prior to joining the drug firm in 2002, Fishman worked as a cardiologist, with a research focus on using zebrafish as a model for cardiovascular disease. He has since, however, helped to usher in a focus on rare diseases and pathway-based research at Novartis. Speaking with Asher Mullard, he looked back on a decade of R&D at Novartis and discussed how R&D trends could evolve in the next 10 years.
Permission from Macmillan Publishers Ltd: Nature Reviews, copyright January 2012

Read the article "An Audience with Mark Fishman"